In a rat model of type 1 diabetes, chronic in vivo administration of a specific pharmacological inhibitor of EGFR abrogated the cardiac benefits of preconditioning implying a critical role of EGFR/ErbB1 in cardiac preconditioning (Akhtar et al., 2012b). This evidence concerns the gene EGFR and type 1 diabetes mellitus.